GLUD1P9

Across TCGA pan-cancer cohorts, GLUD1P9 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated GLUD1P9 data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher GLUD1P9 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated GLUD1P9 expression acts as an unfavorable survival marker, although some lineages such as OV and ESCA show a favorable association.

LUSC, STAD, and UCEC are the cancer types where GLUD1P9 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Tertile	II,III,IV	0.178	0.743	.004	84	view →
STAD	OS	Tertile	II,III,IV	0.176	0.604	<.001	63	view →
UCEC	OS	Tertile	III,IV	0.053	0.588	.005	54	view →
COAD	OS	Tertile	II,III,IV	0.140	0.850	<.001	51	view →
KIRP	OS	Tertile	II,III,IV	0.161	0.771	.002	45	view →
PAAD	DFS	Tertile	All	0.076	0.468	<.001	36	view →
LAML	DFS	Tertile	All	0.187	0.581	.003	36	view →
DLBC	OS	Tertile	III,IV	0.175	0.874	.025	36	view →
OV	OS	Tertile	All	1.000	0.835	.041	30	view →
THYM	OS	Tertile	All	0.352	0.884	<.001	24	view →
KIRC	OS	Tertile	All	0.689	0.883	.017	18	view →
ESCA	DFS	Tertile	III,IV	0.624	0.280	.029	15	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

GLUD1P9–LUSC (OS)

Open the LUSC breakdown →